• Emil Pot, Co-Founder and CEO of Allero Therapeutics

  • 2021/10/20
  • 再生時間： 49 分
  • ポッドキャスト

Emil Pot, Co-Founder and CEO of Allero Therapeutics

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

    In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

    Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

    Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

    Get in touch with Emil.

    Get in Touch with Nick.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

As something that affects as much as 10% of the global population, food allergies are an important topic of discussion in this value-packed episode of High Potential Start-ups.

In episode 3, guest speaker Emil Pot, Co-Founder and CEO of Allero Therapeutics, and host Nick Ross, Co-Founder of Cavenagh Health, delve into numerous talking points surrounding everything from food-related immune disorders to running a successful biotech company. 

Emil’s career started in law, but his keen interest in science quickly led to biotech becoming the central point of his career.

Now, Emil and his team at Allero Therapeutics have developed an innovative solution to treating autoimmune disorders like celiac disease.

Get in touch with Emil.

Get in Touch with Nick.
続きを読む 一部表示

Emil Pot, Co-Founder and CEO of Allero Therapeuticsに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。